Company Overview
About Lightship
Lightship is a clinical research organization (CRO) founded with the mission of reimagining how clinical trials are designed and conducted to dramatically improve participant access and health equity. Traditional clinical research requires participants to travel to major academic medical centers or specialized research sites for frequent, often burdensome in-clinic visits — a model that systematically excludes working adults, rural populations, elderly patients, and underrepresented communities. Lightship designs and executes studies using a spectrum of participation modalities: traditional in-clinic visits, at-home appointments with study nurses who travel to participants, mobile research units that bring clinical procedures to community locations, and digital health tools that enable remote data collection between visits.
Business Model & Competitive Advantage
The company has raised $100M in a Series C funding round, underscoring investor conviction in the decentralized clinical trial (DCT) model as a structural shift in the $50B+ global clinical research industry. Lightship partners with biopharmaceutical companies across therapeutic areas to design studies that are both scientifically rigorous and operationally optimized for participant recruitment and retention. By offering sponsors a single CRO that can coordinate all modalities — site, home, mobile, and digital — Lightship eliminates the complexity of managing multiple vendors for decentralized study components.
Competitive Landscape 2025–2026
Lightship operates at the intersection of two major trends reshaping clinical research: the regulatory and industry movement toward decentralized trials (accelerated by the FDA's 2023 guidance on DCTs) and the broader health equity imperative to make clinical research demographically representative of the populations that will ultimately use the therapies being studied. The company competes with large traditional CROs such as IQVIA, Medpace, and PPD (part of Thermo Fisher), as well as dedicated DCT technology platforms such as Science 37 and Medable.
Key Differentiators
Emerging Innovator
Lightship is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.
Frequently Asked Questions
Similar Brands
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
BioNTech
BioNTech SE was founded in 2008 in Mainz, Germany by Ugur Sahin, Ozlem Tureci, and Christoph Huber with a mission to harness the immune system for individualized cancer treatment. The company pioneere
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
Pliant Therapeutics
Pliant Therapeutics develops small molecule integrin inhibitors targeting the pathological tissue scarring (fibrosis) that drives diseases including idiopathic pulmonary fibrosis (IPF), primary sclero
Genentech
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching
Regeneron
Regeneron Pharmaceuticals was founded in 1988 in Tarrytown, New York by Leonard Schleifer and George Yancopoulos. The company built its reputation on the Velocimmune platform—a proprietary humanized m
Compare Lightship with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Lightship? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Lightship Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Lightship vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →